Royalty Pharma $2 billion senior notes offering
We advised Royalty Pharma on its investment-grade notes offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Klarna Group $1.37 billion IPO
We are advising Klarna on its IPO
Financing for Advent’s $2.5 billion Sapiens take-private acquisition
We are advising the financing sources on the acquisition financing
GSK agreements with Hengrui Pharma to develop up to 12 innovative medicines
We are advising GSK on the transaction
SS&C Technologies $1.03 billion acquisition of Calastone
We are advising SS&C Technologies on the transaction
Weir Group $800 million senior debt offering and cash tender offers
The company issued investment-grade notes due 2030
Mitel emerges from chapter 11
We advised an ad hoc group of secured lenders in connection with Mitel’s chapter 11 proceedings
Ocado Group £100 million high-yield bond tap and £80 million convert repurchase
We advised Ocado on the transactions
Fever acquisition of DICE
We are advising Fever on the acquisition
Clarivate $500 million incremental term loan facility
We advised the borrower on the transaction